A draft 2026 Order proposes explicit Class B controls for THCA-A and THCA-B. We explain its status, what it would change and the questions to ask about testing and compliance.
A draft 2026 Order proposes explicit Class B controls for THCA-A and THCA-B. We explain its status, what it would change and the questions to ask about testing and compliance.
The ACMD has updated its timetable for reviewing the 2018 medicinal cannabis reforms. We explain the latest position, current UK law, NHS and private access, and what to watch for when its report arrives.